Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network
about
Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cellsA role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsuleSelf-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cationsTemporal behavior of capsule enlargement by Cryptococcus neoformans.Rapid identification of Candida species by using nuclear magnetic resonance spectroscopy and a statistical classification strategy.Cas3p belongs to a seven-member family of capsule structure designer proteins.Cryptococcus neoformans dual GDP-mannose transporters and their role in biology and virulence.Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly.Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis.In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.Cryptococcus neoformans hyperfilamentous strain is hypervirulent in a murine model of cryptococcal meningoencephalitis.The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificityCryptococcus neoformans capsule structure evolution in vitro and during murine infectionBinding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophagesPhenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous systemEvidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serumCapsular polysaccharides from Cryptococcus neoformans modulate production of neutrophil extracellular traps (NETs) by human neutrophilsA xylosylphosphotransferase of Cryptococcus neoformans acts in protein O-glycan synthesis.Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigenMultiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformansA yeast under cover: the capsule of Cryptococcus neoformans.Emerging themes in cryptococcal capsule synthesisVariable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences.Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformansMonoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformansCryptococcus neoformans induces antimicrobial responses and behaves as a facultative intracellular pathogen in the non mammalian model Galleria mellonellaEvasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan StructurePhenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans.Comparative hybridization reveals extensive genome variation in the AIDS-associated pathogen Cryptococcus neoformans.Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharidesUnusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans.Allergen1 regulates polysaccharide structure in Cryptococcus neoformans.Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules.
P2860
Q28478860-860D574C-F494-479B-A276-D066B24EB553Q28538344-56F71D4F-B1CD-41C9-BB82-0F4A87A3F5A9Q30479935-A240650F-5E70-40B3-9647-F2B0C6A814EFQ30555314-FF9347D6-BFA2-4BCF-B88E-55651A7D7E51Q33188024-42C35C82-3390-4849-BA63-FB68B19D6AFFQ33560210-510944FD-CB5D-49A0-BD3D-AB7555FF21BEQ33743564-60953C38-B080-4416-86EC-A24705A0C9C0Q33766799-6E6E3ADF-0B19-4A31-866E-AC302075BB91Q33790656-CF479C17-D25A-47C2-A5DB-FC4B92880932Q33894565-F0359DCB-955A-4F09-831D-E3F14690EAF8Q33939999-D6A1621D-7455-46B9-ADEC-CA287604D881Q33946946-17366342-A0DB-400B-B2F6-F912D38B1405Q34001243-4FFA49C7-08A4-49AD-A9D7-F15E4E9A745BQ34005219-A9A12008-D50F-4DA1-8C5C-EE38E4E7A508Q34099803-EFDA5709-B6FB-431A-80C4-198E694DA6B1Q34123230-779EB18A-B8AD-4013-B47E-4BC5FC7F5C0AQ34146274-ED8C91F2-ABA9-410F-8B91-7748E143DF28Q34301177-AAD64C4D-8E78-452C-B270-370AAA844FCAQ34334384-138220E6-74B9-4315-898B-D754337D0345Q34561087-570602E8-C089-4785-A8D5-FAF45FB2F1AFQ34681238-FE1EEF96-B63A-4D28-842A-3956B39ACD98Q34779166-EAE90A83-91CE-4F45-9EE2-2ABB31504B57Q34780084-5820329D-0F35-4ED0-8FA4-72E280C7E782Q35011899-72FA3401-F2B8-4E74-AFEB-028215D7E3DEQ35128286-B607BBF0-206F-4633-A449-A4663154E631Q35138768-43A3C8D2-3AF9-47FF-BC8B-54BA9C7DE35FQ35197055-21C4F16D-6D15-497B-B148-F00E9DFAEE4AQ35197202-0AB45288-9913-4CA8-92F5-13C9DD2BE571Q35291602-36D16B4A-A3E2-41FB-A14A-AF850366EBA1Q35583106-99E9039A-9EE4-40E0-ABC9-3D99F775AA82Q35598044-996F11CB-2EBE-4D6A-8A02-66F933137007Q35923662-E40FD1F2-B7C3-40F6-8525-EB4A94C3BE14Q36154961-5BDB30CA-1F8F-4E6F-B278-2615F513C8A6Q36431950-55CC9A7B-A75A-48CB-B7BA-A64D618DB3B1Q36476671-1D47B64E-B6BF-472C-825D-46EAC1D10AFCQ36642384-8AB0FB90-5B70-4CAC-BCAB-FEF77F086C70Q36662728-0B7F042D-9037-4DD6-8C9D-4DF57F0DA3FCQ36779547-907B2C30-95F7-44BE-9113-926E37AEA5B5Q36950154-A8E1BF53-0D9F-4894-AB03-E6685881F363Q37078933-C99DDA83-66EF-4AB5-916A-BE5766125978
P2860
Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cryptococcus neoformans chemot ...... ated artificial neural network
@ast
Cryptococcus neoformans chemot ...... ated artificial neural network
@en
type
label
Cryptococcus neoformans chemot ...... ated artificial neural network
@ast
Cryptococcus neoformans chemot ...... ated artificial neural network
@en
prefLabel
Cryptococcus neoformans chemot ...... ated artificial neural network
@ast
Cryptococcus neoformans chemot ...... ated artificial neural network
@en
P2093
P2860
P1476
Cryptococcus neoformans chemot ...... ated artificial neural network
@en
P2093
P2860
P304
P577
1998-03-01T00:00:00Z